Includes Interferon gamma-1b, marketed as Actimmune.
Actimmune: Interferon gamma-1b
Manufacturer's information about this protein agent approved by the US FDA for the treatment of chronic granulomatous disease, and severe, malignant osteopetrosis.
MedlinePlus: Interferon Gamma-1b Injection
Features information about dosage, usage, warnings, and side effects.
Last update:January 2, 2007 at 16:33:30 UTC